我要投票 沂蒙在玻璃胶行业中的票数:163
· 外 推 电 报 ·
2025-02-01 07:39:30 星期六

【沂蒙是哪个国家的品牌?】

沂蒙是什么牌子?「沂蒙」是 山东省药用玻璃股份有限公司 旗下著名品牌。该品牌发源于山东省淄博市,由创始人扈永在1993-11-08期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

山东省药用玻璃股份有限公司位于山东省沂源县城,这里是中国药用玻璃工业发源地之一,也是中国玻璃工业发达的地区。

山东省药用玻璃股份有限公司创立于1970年,以医药、食品、日用品行业为服务对象,生产各种药用、食品、日用品包装材料。2002年1月24日经中国证监会核准发行3200万股A股,并于2002年6月3日挂牌交易。

经过近40年的奋力拼搏,使山东药玻一步步成长为闻名世界的药用包装行业企业,产品市场覆盖32个省、市、自治区,并远销欧、美、俄、日、韩、东南亚等60多个国家和地区,每年为制药、食品、化妆工业提供百亿支各种规格的包装产品,这些产品中有模制抗生素瓶系列产品、管制瓶系列产品、棕色瓶系列产品、中性硼硅玻璃系列产品、输液瓶系列产品、日化瓶系列产品、食品瓶瓷砖 系列产品、丁基橡胶塞系列产品、预灌封注射器系列产品、铝塑盖系列产品、塑料瓶系列产品等,适用于制药工业粉针、水针、输液、口服液、冻干、生物制剂、片剂等不同药品制剂及食品、化妆品的包装需要,并有各种材质、瓶型及规格可供选择。其中公司的主导产品模制抗生素瓶年产量达90多亿支,药用丁基橡胶塞年产量48亿支,销往国内外各制药企业。

此外,山东药玻不断加大投入,采用最新科技,提高制造系列的自动化程度,完善生产工艺和质量控制手段,开发新的品种。引进了美国艾姆哈特行列式制瓶机生产线,实现了产品的自动检验和自动包装,提高了玻璃制品的成品率。强大的技术开发能力,不断满足用户的新需求成为可能。公司已现有科技成果172项,专利技术49项。

积40年从事药用玻璃制造的丰富经验和雄厚实力,山东药玻建立了完善的质量保证体系,对玻璃制造的每一个环节进行了严格的控制,在同行业中率先通过质量体系认证、环境体系认证和安全体系认证,并始终持续的改进保证体系,提升产品的品质,从而取得了和医药工业良好的配合,赢得了医药界人士的认可和赞赏。

英文翻译:Shandong Pharmaceutical Glass Co., Ltd. is located in Yiyuan County, Shandong Province, which is one of the birthplaces of China's pharmaceutical glass industry and the developed area of China's glass industry. Shandong Pharmaceutical Glass Co., Ltd. was founded in 1970, with the pharmaceutical, food, daily necessities industry as the service object, to produce a variety of pharmaceutical, food, daily necessities packaging materials. On January 24, 2002, China Securities Regulatory Commission approved the issuance of 32 million a shares, which was listed for trading on June 3, 2002. After nearly 40 years of hard work, Shandong Pharmaceutical glass has gradually grown into a world-famous pharmaceutical packaging industry enterprise. Its product market covers 32 provinces, cities and autonomous regions, and is exported to more than 60 countries and regions such as Europe, the United States, Russia, Japan, South Korea, Southeast Asia, etc. every year, it provides tens of billions of packaging products of various specifications for pharmaceutical, food and cosmetic industries, among which there are model antibiotics Bottle series products, control bottle series products, brown bottle series products, neutral borosilicate glass series products, infusion bottle series products, daily chemical bottle series products, food bottle ceramic tile series products, butyl rubber plug series products, pre filling syringe series products, aluminum plastic cover series products, plastic bottle series products, etc., suitable for powder injection, water injection, infusion, oral liquid in pharmaceutical industry , freeze-drying, biological agents, tablets and other different pharmaceutical preparations, food and cosmetics packaging needs, and a variety of materials, bottle types and specifications to choose from. Among them, the annual output of the company's leading product molding antibiotic bottles is more than 9 billion, and the annual output of medical butyl rubber plugs is 4.8 billion, which are sold to various pharmaceutical enterprises at home and abroad. In addition, Shandong Pharmaceutical glass has continuously increased investment, adopted the latest technology, improved the automation level of manufacturing series, improved production process and quality control means, and developed new varieties. The production line of American Emhart determinant bottle making machine is introduced to realize the automatic inspection and packaging of products and improve the yield of glass products. It is possible to continuously meet the new needs of users with powerful technology development capabilities. The company has 172 scientific and technological achievements and 49 patented technologies. With 40 years of rich experience and strong strength in pharmaceutical glass manufacturing, Shandong Pharmaceutical glass has established a perfect quality assurance system, strictly controlled every link of glass manufacturing, took the lead in the industry in passing the quality system certification, environmental system certification and safety system certification, and constantly improved the assurance system to improve the quality of products, so as to achieve and The good cooperation of the pharmaceutical industry has won the recognition and appreciation of the people in the pharmaceutical industry.

本文链接: https://www.waitui.com/brand/3548a554a.html 联系电话:05333259029

千城特选小程序码

7×24h 快讯

报告:预计今年上半年楼市止跌,杭州等8城将率先回稳

1月31日,克而瑞地产研究中心发布报告称,预计2025年上半年楼市止跌基本可以完成,而下半年或将延续弱复苏走势。预期2025年将有8个城市成交规模率先回稳,这8个城市分别为:杭州、上海、成都、西安、天津、深圳、合肥和北京。(澎湃新闻)

2小时前

呷哺集团:除夕至大年初三全国门店销售额提升明显

除夕至大年初三,呷哺呷哺全国门店销售额提升明显,尤其是河北、安徽、山东、湖南、湖北、河南、新疆、陕西等区域销售额较上年同期最高提升20%。此外,呷哺集团旗下另一特色火锅品牌湊湊的客流量比去年增长约20%。(证券时报·e公司)

2小时前

雪佛龙第四季度调整后每股收益2.06美元,低于预期

雪佛龙第四季度调整后每股收益2.06美元,预期2.11美元。预计在2025-2026年将进一步提升产量。在二叠纪盆地,预计到2025年每日石油当量将达到100万桶;美国墨西哥湾的石油日产量将在2026年达到30万桶油当量。2024年全球及美国的产量分别增长了7%和19%,创下历史新高。公司每年维持100亿至200亿美元的股份回购。(新浪财经)

2小时前

日本拟对十余种半导体相关物项实施出口管制,商务部回应

商务部新闻发言人就日本拟实施半导体等多项出口管制措施事答记者问。有记者问:1月31日,日本政府宣布拟对十余种半导体相关物项实施出口管制,并将多家中国企业列入“最终用户清单”等。请问中方对此有何评论? 答:中方注意到有关情况。一段时间以来,个别国家泛化国家安全概念,滥用出口管制措施,对中国半导体等产业实施制裁打压。日方拟实施的出口管制措施,将影响产业链供应链安全稳定,干扰企业间正常商业往来,损害两国企业利益。(央视网)

2小时前

美股周五高开,12月PCE通胀数据符合预期

美股周五高开。投资者正在评估苹果公司和其他知名科技企业的财报。特朗普再次对墨西哥和加拿大发出关税威胁。美联储“最青睐”的通胀指标——核心PCE物价指数年率为2.8%,连续第三个月企稳在该水平,符合市场预期。12月PCE物价指数符合预期,继续保持相对温和的增长,这或许为未来美联储进一步降息提供支持。(环球市场播报)

2小时前

本页详细列出关于创世纪ChuangShiJi的品牌信息,含品牌所属公司介绍,创世纪ChuangShiJi所处行业的品牌地位及优势。
咨询